| VAŠKŮ, Anna, Miroslav SOUČEK, Vladimír ZNOJIL, Ivan ŘIHÁČEK, Karel CÍDL, Lenka STŘELCOVÁ a Jiří VÁCHA. Does angiotensin I-converting enzyme inhibitor therapy have an antiproliferative effect on the blood-forming bone marrow? Experimental Hematology. Int Soc for Exper Hematol, 1998, roč. 26, č. 4, s. 277-278. ISSN 0301-472X. |
Další formáty:
BibTeX
LaTeX
RIS
@article{198856,
author = {Vašků, Anna and Souček, Miroslav and Znojil, Vladimír and Řiháček, Ivan and Cídl, Karel and Střelcová, Lenka and Vácha, Jiří},
article_number = {4},
keywords = {ACEI; RBC},
language = {eng},
issn = {0301-472X},
journal = {Experimental Hematology},
title = {Does angiotensin I-converting enzyme inhibitor therapy have an antiproliferative effect on the blood-forming bone marrow?},
volume = {26},
year = {1998}
}
TY - JOUR
ID - 198856
AU - Vašků, Anna - Souček, Miroslav - Znojil, Vladimír - Řiháček, Ivan - Cídl, Karel - Střelcová, Lenka - Vácha, Jiří
PY - 1998
TI - Does angiotensin I-converting enzyme inhibitor therapy have an antiproliferative effect on the blood-forming bone marrow?
JF - Experimental Hematology
VL - 26
IS - 4
SP - 277
EP - 277
PB - Int Soc for Exper Hematol
SN - 0301472X
KW - ACEI
KW - RBC
N2 - One year ACE inhibitor therapy in 11 patients with essential hypertension was found to cause a decrease in red blood cell counts , together with an increased corpuscular volume in these erythrocytes. Thus, IACE therapy could influence local RAS system in blood-forming bone marrow.
ER -
VAŠKŮ, Anna, Miroslav SOUČEK, Vladimír ZNOJIL, Ivan ŘIHÁČEK, Karel CÍDL, Lenka STŘELCOVÁ a Jiří VÁCHA. Does angiotensin I-converting enzyme inhibitor therapy have an antiproliferative effect on the blood-forming bone marrow? \textit{Experimental Hematology}. Int Soc for Exper Hematol, 1998, roč.~26, č.~4, s.~277-278. ISSN~0301-472X.
|
